The MarketWatch News Department was not involved in the creation of this content. AUSTIN, Texas and TOKYO, Sept. 24, 2025 /PRNewswire/ --The Digital Migraine Treatment Devices Market is witnessing ...
More than a billion people worldwide struggle to find relief from the unbearable pain of migraine. But research is leading to ...
MINNEAPOLIS — Remote electrical neuromodulation (REN) appears to be a safe and effective option for a broad range of migraine types including migraine with or without aura and chronic migraine in ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The Nerivio device offered consistent safety, efficacy ...
Please provide your email address to receive an email when new articles are posted on . Migraine pain relief was reported in more than 75% of users over 3 years. Treatment intensity increased by a ...
DARIEN, Conn., Nov. 3, 2025 /PRNewswire/ -- Medical device maker CEFALY Technology announced today that CEFALY Connected has become the most frequently used neuromodulation device for migraine among ...
Series B funding round led by Innovation Industries, with participation from Invest-NL, EIC Fund, and existing investors Inkef, Panakès Partners, SHS Capital, Dolby Family Ventures, Brabant ...
Theranica, a neuromodulation therapeutics company advancing clinically validated, drug-free treatments for idiopathic pain conditions, today announced that health insurance coverage for its ...
ShiraTronics Initiates IDE Pivotal Study of Implantable Neuromodulation Therapy for Chronic Migraine
First Implants of Innovative Device Completed in the United States and Australia Migraine affects nearly 2% of the global population and is often marked by severe, pulsating headaches, sensory ...
Prompt use of remote electrical neuromodulation improved migraine outcomes, underscoring that timely treatment is crucial for optimizing clinical results and reducing disease burden. Initiating remote ...
TAMPA, Fla.--(BUSINESS WIRE)--Neurolief Ltd., a neurotechnology innovator, today announces that it has entered into an exclusive agreement with Sawai Pharmaceutical Co., Ltd. for the development and ...
SAN DIEGO -- An investigational device that delivered conditioned room air intranasally treated acute migraine attacks without drugs, a randomized sham-controlled study showed. Compared with sham, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results